ViewFinder Software Version
Overview
ViewFinder Software Version by Elaitra is an FDA-cleared AI tool designed to enhance and accelerate breast cancer screening using Digital Breast Tomosynthesis (DBT). It addresses the persistent challenge radiologists face in accurately matching the same tissue area across different views in 3D mammography. The software provides real-time visual guidance: when a radiologist hovers over an area in one view, ViewFinder dynamically identifies and displays the corresponding location in other views, complete with a confidence-based outline and a front-to-back ‘coronal’ visualization.
This dynamic assistance significantly improves 3D navigation and helps to reduce guesswork, which is particularly crucial for the precise assessment of very small lesions. ViewFinder is characterized as an ‘interactive’ or ’embodied’ AI system, working alongside clinicians in real-time to augment their spatial reasoning rather than replacing it. It is a software-only solution that can operate on compatible client-server environments with monitors cleared for mammography diagnostics. The tool is vendor-agnostic and supports deployment both on-premises and through approved cloud providers.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Real-time visual guidance for cross-view tissue matching in DBT
- Dynamic identification and display of corresponding tissue locations
- Confidence-based outline and coronal visualization
- Enhances 3D navigation and reduces guesswork
- Improves diagnostic accuracy, especially for small lesions
- Interactive or 'embodied' AI system
- Vendor-agnostic deployment
- Deployment on-premises or through approved cloud providers
- Proprietary Artificial Intelligence and Machine Learning algorithms (locked)
- Dedicated softcopy review environment for DBT
Use Cases
- Breast cancer screening using Digital Breast Tomosynthesis (DBT)
- Diagnostic interpretation of DBT images
- Improving radiologist efficiency and accuracy in cross-view correlation
- Assessing suspicious lesions and improving diagnostic confidence
- Enhancing spatial reasoning during breast imaging work-ups
- Optimizing workflow for radiologists interpreting 3D mammography
What Physicians Need to Know
ViewFinder offers a significant advantage in Digital Breast Tomosynthesis (DBT) interpretation by dynamically matching tissue across different views, thereby reducing cognitive load and improving diagnostic accuracy, especially for subtle lesions. Its real-time visual guidance can enhance spatial reasoning and streamline workflow. Given its FDA clearance and evidence from peer-reviewed studies demonstrating reduced localization errors, it presents a valuable tool for augmenting radiologist capabilities in breast cancer screening. Consider its vendor-agnostic nature for seamless integration into existing imaging ecosystems.
ViewFinder is designed for flexible integration, capable of operating as a standalone application or integrating with existing medical image management and processing systems. Its vendor-agnostic architecture supports deployment both on-premises and via approved cloud providers. Strategic collaborations, such as with DeepLook Medical, highlight its potential for enhanced visualization capabilities when combined with other advanced imaging platforms, indicating a commitment to interoperability within broader radiology workflows.
Details
| Category | Oncology AI, Radiology & Imaging AI |
| Pricing | Not disclosed — N/A |
| Deployment | On-premises, Cloud |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated ViewFinder Software Version 1.1 received 510(k) premarket notification clearance (K223501) from the U.S. FDA on April 21, 2023. It is classified as a Class II Medical Image Management and Processing System (21 CFR 892.2050) with product code QIH. |
| Integrations | |
| EHR | Not specified |
| Specialties | Oncology, Radiology |
What the Web Says
ViewFinder Software by Elaitra is an AI-driven tool designed to assist radiologists in accurately interpreting 3D mammograms for breast cancer detection. It is FDA-cleared and MHRA-approved, indicating its compliance with regulatory standards in the USA and UK. The software can function as a standalone application or integrate with existing image management systems, aiming to reduce cognitive load and improve diagnostic confidence.
Overall: PositiveStrengths
- AI-driven for accurate breast cancer detection
- FDA-cleared and MHRA-approved
- Can function standalone or integrate with existing systems
- Aims to reduce cognitive load and improve diagnostic confidence
- 92% of physicians would use it in their practice
- Enhances accuracy and efficiency in finding lesions
Limitations
- Pricing details require contacting the vendor
- No specific cons from physicians or healthcare IT found in the provided search results
- Not enough reviews on G2 to provide buying insight for 'viewflip' which is a different software
- Some general 'Viewfinder' apps (not Elaitra's) have issues with outdated OS versions or being complicated to understand
Based on reviews from: Elaitra, Reddit, G2, Capterra
Last updated: 2026-07-18
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate ViewFinder Software Version
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for ViewFinder Software Version.
